Y-Intercept (HK)’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,866
Closed -$239K 1742
2023
Q3
$239K Buy
+12,866
New +$146K 0.02% 852
2023
Q1
Sell
-11,491
Closed -$142K 1641
2022
Q4
$142K Buy
+11,491
New +$163K 0.02% 870

Y-Intercept (HK)'s ICPT Position: Q4 2023 in Review

Y-Intercept (HK) sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 12,866 shares — an estimated $239K sold.

Y-Intercept (HK) first reported a position in ICPT in Q4 2022 and held it in 2 quarters. The position peaked at $239K in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • Y-Intercept (HK) reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • Y-Intercept (HK) sold 12,866 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $239K.
  • Y-Intercept (HK) first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2022 and held it in 2 quarters.
  • Y-Intercept (HK)'s Intercept Pharmaceuticals, Inc. position peaked at $239K in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on Y-Intercept (HK)'s 13F filing for Q4 2023, filed 13 Feb 2024.